Last reviewed · How we verify
Magnesium Orthophosphate — Competitive Intelligence Brief
unknown
magnesium phosphate
Other
Live · refreshed every 30 min
Target snapshot
Magnesium Orthophosphate (magnesium phosphate). Magnesium Orthophosphate works by binding to phosphate groups in the body, potentially influencing various cellular processes.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Magnesium Orthophosphate TARGET | magnesium phosphate | unknown | magnesium phosphate |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape (magnesium phosphate class)
- · 1 drug in this class
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Magnesium Orthophosphate CI watch — RSS
- Magnesium Orthophosphate CI watch — Atom
- Magnesium Orthophosphate CI watch — JSON
- Magnesium Orthophosphate alone — RSS
- Whole magnesium phosphate class — RSS
Cite this brief
Drug Landscape (2026). Magnesium Orthophosphate — Competitive Intelligence Brief. https://druglandscape.com/ci/magnesium-phosphate. Accessed 2026-06-10.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing